(Total Views: 737)
Posted On: 04/20/2021 1:59:16 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
I think it's fairly obvious that we are at a turning point with Covid. Variants are spreading everywhere, even double variants now, and people infected with more than one kind of covid at the same time! The P1 variant from Brazil is taking over in Canada and has been found in at least half of the U.S. states. The vaccines will not be effective on these variants, meanwhile the U.S. parties and protests on without a care in the world.
So far, the U.S. has pushed their vaccine program at the expense of therapeutics. They have given big pharma millions and millions of dollars, and one by one their drugs have failed. Fauci's darling Remdesivir is doing more harm than good, but still NIH keeps trialing it with everything under the sun. Remember AZT anyone?
Leronlimab is proven safe, and other countries will soon realize they have nothing to lose using it on their critical patients. It's only a matter of time before Leronlimab patients start walking out of ICU's and telling their stories. But those patients won't be Americans, they will come from countries with socialized medicine and universal health care, where big pharma doesn't control the media coverage, where every other ad on the television isn't for a big pharma drug with a list of side effects a mile long.
I don't know how many recovered patients will be necessary to usurp Remdesivir as standard of care here in the U.S. Perhaps someone should ask the eight plus FDA officials with ties to Gilead? But I'm very, very happy to be invest in this company, because Leronlimab is truly remarkable and I know it will be saving lives somewhere soon.
So far, the U.S. has pushed their vaccine program at the expense of therapeutics. They have given big pharma millions and millions of dollars, and one by one their drugs have failed. Fauci's darling Remdesivir is doing more harm than good, but still NIH keeps trialing it with everything under the sun. Remember AZT anyone?
Leronlimab is proven safe, and other countries will soon realize they have nothing to lose using it on their critical patients. It's only a matter of time before Leronlimab patients start walking out of ICU's and telling their stories. But those patients won't be Americans, they will come from countries with socialized medicine and universal health care, where big pharma doesn't control the media coverage, where every other ad on the television isn't for a big pharma drug with a list of side effects a mile long.
I don't know how many recovered patients will be necessary to usurp Remdesivir as standard of care here in the U.S. Perhaps someone should ask the eight plus FDA officials with ties to Gilead? But I'm very, very happy to be invest in this company, because Leronlimab is truly remarkable and I know it will be saving lives somewhere soon.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)